Abstract
Cats diagnosed as aortic thromboembolism were performed with monotherapy using anticoagulant agent or combined therapy using thrombolytic agent, the efficacy of those therapies were discussed. Survival time, hours of forelimb or hind limb paralysis onset, palpable or not of pressure of femoral artery (unilateral or bilateral) on the first day, the days for palpable pressure of femoral artery, and pulmonary edema or not on the first day, were discussed between each therapy group. Fifteen cats were identified as having had a prescription filled for anticoagulant therapy using low molecular weight heparins (low molecular weight heparins group: n=8) or thrombolytic therapy using tissue plasminogen activator (low molecular weight heparins group+tPA group: n=7) between 2002 and 2011. The half survival time of low molecular weight heparins group and low molecular weight heparins group+tPA group were 742 and 5 days, respectively, in low molecular weight heparins group, survival time was longer significantly than that of low molecular weight heparins group+tPA group (p<0.05).
